[go: up one dir, main page]

GB0117144D0 - Process - Google Patents

Process

Info

Publication number
GB0117144D0
GB0117144D0 GB0117144A GB0117144A GB0117144D0 GB 0117144 D0 GB0117144 D0 GB 0117144D0 GB 0117144 A GB0117144 A GB 0117144A GB 0117144 A GB0117144 A GB 0117144A GB 0117144 D0 GB0117144 D0 GB 0117144D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0117144A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0117144A priority Critical patent/GB0117144D0/en
Publication of GB0117144D0 publication Critical patent/GB0117144D0/en
Priority to PCT/GB2002/003185 priority patent/WO2003006462A1/en
Priority to ARP020102596 priority patent/AR034867A1/en
Ceased legal-status Critical Current

Links

GB0117144A 2001-07-13 2001-07-13 Process Ceased GB0117144D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0117144A GB0117144D0 (en) 2001-07-13 2001-07-13 Process
PCT/GB2002/003185 WO2003006462A1 (en) 2001-07-13 2002-07-10 Processes for the manufacture of thrombin inhibitors and n-pyridin-4-yl-oxazolidin-2-ones as intermediate therefor
ARP020102596 AR034867A1 (en) 2001-07-13 2002-07-11 INTERMEDIARY PIRIDINE 4-SUBSTITUTE COMPOUND, PROCEDURE TO PREPARE IT, PROCEDURE TO PREPARE AN INTERMEDIATE PIRIDINE 4-ALKYLAMINE COMPOSITE AND PROCEDURE TO PREPARE A BENZAMIDA COMPOUND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0117144A GB0117144D0 (en) 2001-07-13 2001-07-13 Process

Publications (1)

Publication Number Publication Date
GB0117144D0 true GB0117144D0 (en) 2001-09-05

Family

ID=9918463

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0117144A Ceased GB0117144D0 (en) 2001-07-13 2001-07-13 Process

Country Status (3)

Country Link
AR (1) AR034867A1 (en)
GB (1) GB0117144D0 (en)
WO (1) WO2003006462A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230302B1 (en) 2000-10-20 2015-12-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds and pharmaceutical compositions containing them
CN100450998C (en) 2003-11-11 2009-01-14 卫材R&D管理有限公司 Process for the preparation of urea derivatives
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006030941A1 (en) 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor
EP1797881B1 (en) 2004-09-17 2009-04-15 Eisai R&D Management Co., Ltd. Medicinal composition with improved stability and reduced gelation properties
EP2281901B1 (en) 2005-08-02 2013-11-27 Eisai R&D Management Co., Ltd. Anti-tumour pharmaceutical composition with angiogenesis inhibitors
EP2036557B1 (en) 2006-05-18 2015-10-21 Eisai R&D Management Co., Ltd. Antitumor agent for thyroid cancer
CN101511793B (en) 2006-08-28 2011-08-03 卫材R&D管理有限公司 Antineoplastic agents against undifferentiated gastric cancer
AU2008211952B2 (en) 2007-01-29 2012-07-19 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated-type of gastric cancer
JP5638244B2 (en) 2007-11-09 2014-12-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Combination of angiogenesis inhibitors and antitumor platinum complexes
MX2012014776A (en) 2010-06-25 2013-01-29 Eisai R&D Man Co Ltd Antitumor agent using compounds having kinase inhibitory effect in combination.
MX2013009931A (en) 2011-04-18 2013-10-01 Eisai R&D Man Co Ltd Therapeutic agent for tumor.
US9945862B2 (en) 2011-06-03 2018-04-17 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
US9334239B2 (en) 2012-12-21 2016-05-10 Eisai R&D Management Co., Ltd. Amorphous form of quinoline derivative, and method for producing same
US10517861B2 (en) 2013-05-14 2019-12-31 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
CN106660964B (en) 2014-08-28 2021-09-03 卫材R&D管理有限公司 High-purity quinoline derivative and process for producing the same
PL3263106T3 (en) 2015-02-25 2024-04-02 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
KR102662228B1 (en) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 Combination of PD-1 antagonists and VEGFR/FGFR/RET tyrosine kinase inhibitors to treat cancer
ES2886107T3 (en) 2015-06-16 2021-12-16 Prism Biolab Co Ltd Antineoplastic
AU2016309356B2 (en) 2015-08-20 2021-06-24 Eisai R&D Management Co., Ltd. Tumor therapeutic agent
MX380144B (en) 2017-02-08 2025-03-12 Eisai R&D Man Co Ltd PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT.
CA3061888A1 (en) 2017-05-16 2018-11-22 Eisai R&D Management Co., Ltd. Treatment of hepatocellular carcinoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
GB9821483D0 (en) * 1998-10-03 1998-11-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2003006462A1 (en) 2003-01-23
AR034867A1 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
GB0111020D0 (en) Process
GB0120835D0 (en) Process
GB0109555D0 (en) Process
GB0117144D0 (en) Process
GB0113645D0 (en) Process
GB0113789D0 (en) Process
GB0127423D0 (en) Process
GB0112801D0 (en) Process
GB0112792D0 (en) Process
GB0117090D0 (en) Process
GB0112331D0 (en) Process
GB0116212D0 (en) Process
GB0112789D0 (en) Process
GB2393678B (en) Cast-bonding process
GB0113370D0 (en) Process
GB0114033D0 (en) Process
GB0112327D0 (en) Process
GB0113772D0 (en) Process
GB0113922D0 (en) Process
GB0112794D0 (en) Process
GB0119042D0 (en) Process
GB0124836D0 (en) Process
GB0113786D0 (en) Process
GB0115839D0 (en) Process
GB0118418D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)